Search criteria | ||||
A cross-sectional survey to evaluate prescribers' knowledge and understanding of safety messages following Dengvaxia® product information update | ||||
Mariana F Almas 1, Massoud Toussi 2, Elisa Valero 3, Annick Moureau 4, Lydie Marcelon | ||||
1IQVIA Real World Solutions, Porto Salvo, Portugal. 2IQVIA Real World &Analytics Solutions, La Défense, France. 3Global Pharmacovigilance, Sanofi Pasteur, Lyon, France. 4Global Biostatistical Sciences, Sanofi Pasteur, Marcy l'Etoile, France. 5Epidemiology and Benefit Risk, Global Pharmacovigilance, Sanofi Pasteur, Lyon, France. | ||||
Pharmacoepidemiol Drug Saf . 2022 Jul;31(7):758-768. doi: 10.1002/pds.5447. Epub 2022 May 13 |
||||
, Article | ||||
, Brazil, Thailand | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/35505623/ | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Risk Management & REMS | 2022 | English | , Clinical setting: Primary care, Epidemiological study, Survey research | |
Physician awareness and understanding of primary immunodeficiency disorders: a web-based study in Japan | ||||
Kohsuke Imai 1, Akinori Oh 2, Ayumi Morishita 3, Yoichi Inoue 2* (rwesheorj 3) | ||||
1) Department of Pediatrics, National Defense Medical College, Tokorozawa, Japan 2) Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan 3) IQVIA Solutions Japan K.K, Tokyo, Japan | ||||
Immunological Medicine |
||||
, Article | ||||
, Japan | ||||
Abstract: https://www.tandfonline.com/doi/full/10.1080/25785826.2022.2137966 | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2022 | English | , Survey research | |
Concerns, quality of life, access to care and productivity of the general population during the first 8 weeks of the coronavirus lockdown in Belgium and the Netherlands | ||||
Hanne van Ballegooijen 1, Lucas Goossens 2, Ralph H Bruin 3, Renée Michels 3, Marieke Krol 3 | ||||
1IQVIA, Herikerbergweg 314, 1101 CT, Amsterdam, The Netherlands. hanne.vanballegooijen@iqvia.com. 2Erasmus University Rotterdam, Erasmus School of Health Policy & Management, Rotterdam, The Netherlands. 3IQVIA, Herikerbergweg 314, 1101 CT, Amsterdam, The Netherlands. | ||||
1 IQVIA, Herikerbergweg 314, 1101 CT Amsterdam, The Netherlands. 2 Erasmus University Rotterdam, Erasmus School of Health Policy & Management, Rotterdam, The Netherlands BMC Health Services Research (2021) 21:227 PMID: 33712010 PMCID: PMC7953179 DOI: 10.1186/s12913-021-06240-7 |
||||
, Article | ||||
, Netherlands | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/33712010/ | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Health status & patient reported outcomes, Immunology and Vaccination | 2021 | English | , Observational study, Patient questionnaire, Population Based Study, Public Health, Quality of life, Survey research | |
Cost-effectiveness of the cell-based quadrivalent versus the standard egg-based quadrivalent influenza vaccine in Germany | ||||
Rui Cai 1, Laetitia Gerlier 2, Martin Eichner 3 4, Markus Schwehm 5, Sankarasubramanian Rajaram 6, Joaquin Mould-Quevedo 7, Mark Lamotte 2 | ||||
1IQVIA Real World Solutions, Amsterdam, The Netherlands. 2IQVIA (Global HEOR), Zaventem, Belgium. 3Epimos GmbH, Dusslingen, Germany. 4Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany. 5ExploSYS GmbH, Leinfelden-Echterdingen, Germany. 6Seqirus Vaccines Ltd, Maidenhead, UK. 7Seqirus Vaccines, Summit, NJ, USA | ||||
Journal of Medical Economics 2021. https://doi.org/10.1080/13696998.2021.1908000 |
||||
, Article | ||||
, Germany | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/33761803/ | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2021 | English | , Clinical setting: Primary care, Cost effectiveness | |
Impact of extending direct antiviral agents (DAA) availability in France: an observational cohort study (2015-2019) of data from French administrative healthcare databases (SNDS) | ||||
Stanislas Pol 1, Fayssoil Fouad 2, Magali Lemaitre 2, Ingrid Rodriguez 3, Olivier Lada 3, Pascaline Rabiega 2, Elias Benabadji 3, Françoise Roudot-Thoraval 4 | ||||
1Université de Paris, département d'hépatologie et d'addictologie, 75014 Cochin (AP-HP), Paris, France. 2IQVIA, 92400 Courbevoie, France. 3Gilead Sciences, 92100 Boulogne Billancourt, France. 4Service d'hépatologie, Henri-Mondor (AP-HP), 94010, Créteil, France. | ||||
Lancet Reg Health Eur . 2021 Dec 11;13:100281. doi: 10.1016/j.lanepe.2021.100281. eCollection 2022 Feb. |
||||
, Abstract | ||||
, France | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/34950924/ | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Infectious disease | 2021 | English | , Observational study, Population Based Study, Predictive analytics | |
Epidemiology, Mortality and Healthcare Resource Utilization Associated With Systemic Sclerosis-Associated Interstitial Lung Disease in France | ||||
Vincent Cottin 1, Sophie Larrieu 2, Loic Boussel 3 4, Salim Si-Mohamed 3 4, Fabienne Bazin 2, Sébastien Marque 2, Jacques Massol 5, Françoise Thivolet-Bejui 6, Lara Chalabreysse 6, Delphine Maucort-Boulch 7 8 9 10, Stéphane Jouneau 11, Eric Hachulla 12, Julien Chollet 13, Mouhamad Nasser 1 | ||||
1 Hôpital Louis Pradel, Centre Coordonnateur National de Référence des Maladies Pulmonaires Rares, Hospices Civils de Lyon, UMR754 INRAE and Université Claude Bernard Lyon 1, Member of ERN-LUNG, RespiFil, OrphaLung, Lyon, France. 2 IQVIA - RWS La Défense, Courbevoie, France. 3 Département de Radiologie, Hospices Civils de Lyon, Lyon, France. 4 Université Lyon, INSA-Lyon, Université Claude Bernard Lyon 1, UJM-Saint Etienne, CNRS Inserm, CREATIS UMR 5220, Lyon, France. 5 AIXIAL - Paris, Paris, France. 6 Département d'anatomo-pathologie, Hospices Civils de Lyon, Lyon, France. 7 Hospices Civils de Lyon, Pôle Santé Publique, Service de Biostatistique et Bioinformatique, Lyon, France. 8 Université de Lyon, Lyon, France. 9 Université Lyon 1, Villeurbanne, France. 10 CNRS, UMR 5558, Laboratoire de Biométrie et Biologie Évolutive, Équipe Biostatistique-Santé, Villeurbanne, France. 11 Centre Hospitalier Universitaire de Rennes, Centre de Compétences pour les Maladies Pulmonaires Rares, Univ Rennes, Inserm, EHESP, IRSET (Institut de recherche en santé, environnement et travail), RespiFil, OrphaLung, Rennes, France. 12 Hôpital Claude Huriez, Centre National de Référence des maladies auto-immunes systémiques rares (CeRAINO), CHU de Lille, Lille, France. 13 Boehringer Ingelheim France SAS, Paris, France. | ||||
Front Med (Lausanne) . 2021 Aug 30;8:699532. doi: 10.3389/fmed.2021.699532. |
||||
, Abstract | ||||
, France | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/34552943/ | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Respiratory disease | 2021 | English | , Observational study, Population Based Study | |
Impact des nouveaux traitements (AAD) de l’hépatite C dans la population générale et les populations à risque : étude réalisée en France à partir des données du SNDS sur la période 2015-2019 | ||||
PascalineRabiéga1, StanislasPol2, FayssoilFouad1, IngridRodriguez3, OlivierLada3, MagaliLemaitre1, EliasBenabadji3, FrançoiseRoudot-Thoraval4 | ||||
1 IQVIA, Courbevoie, France 2 Cochin (AP-HP), Paris, France 3 Gilead Sciences, Boulogne Billancourt, France 4 Henri-Mondor (AP-HP), Créteil, France | ||||
https://doi.org/10.1016/j.respe.2021.05.010 |
||||
, Article | ||||
, France | ||||
Abstract: https://www.sciencedirect.com/science/article/abs/pii/S0398762021002455 | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Infectious disease | 2021 | French | , Methodology, Population Based Study | |
The background occurrence of selected clinical conditions prior to the start of an extensive national vaccination program in Japan | ||||
Tomotaka Sobue 1 2, Haruhisa Fukuda 3, Tetsuya Matsumoto 4, Bennett Lee 5, Shuhei Ito 5*, Satoshi Iwata 6 (rwesheorj A) | ||||
1) Division of Environmental Medicine and Population Science, Graduate School of Medicine, Osaka University, Osaka, Japan 2) Keio University School of Medicine, Tokyo, Japan 3) Department of Health Care Administration and Management, Kyushu University, Fukuoka, Japan 4) Department of Infectious Diseases, International University of Health and Welfare, Narita, Japan 5) Vaccine Medical Affairs, Pfizer Japan Inc., Tokyo, Japan 6) Department of Infectious Diseases, National Cancer Center Hospital, Tokyo, Japan | ||||
PLOS One |
||||
, Article | ||||
, Japan | ||||
Abstract: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0256379 | ||||
Condition | Year | Language | Analysis type | |
, COVID-19, Immunology and Vaccination | 2021 | English | , Database Study, Literature Review | |
Cost-Effectiveness of the CELL-Based Quadrivalent Versus the Standard Egg-Based Quadrivalent Influenza Vaccine in Germany. Results of a Dynamic Transmission Modelling Approach | ||||
Cai R, Gerlier L, Eichner M, Schwehm M, Majaram S, Mould-Quevedo J, Lamotte M. | ||||
IQVIA HEOR Zaventem | ||||
ISPOR Europe 2020 Virtual conference Milano Nov 16-19 Abstract ID# 105463 |
||||
, Poster | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2020 | English | , Clinical setting: Primary care, Cost effectiveness | |
Prévalence et mortalité de la pneumopathie interstitielle diffuse associée à la sclérodermie systémique (PID-ScS) en France : données du Système National des Données de Santé (SNDS) | ||||
M.Nasser, P.Rabiega, L.Boussel, S.Si-Mohamed, V.Barbet, S.Marque, J.Massol, F.Thivolet-Bejui, L.Chalabreysse, D.Maucort-Boulch, S.Jouneau, E.Hachulla, J.Chollet, V.Cottin | ||||
1 Pneumologie, Hospices Civils de Lyon - HCL, Lyon 2 RWS, IQVIA, Courbevoie 3 Imagerie médicale, Hospices Civils de Lyon - HCL, Lyon 4 Consultant, Aixial, Boulogne-Billancourt 5 Anatomie et cytologie pathologiques, Hospices Civils de Lyon - HCL, Lyon 6 Biostatistiques, Hospices Civils de Lyon - HCL, Lyon 7 Pneumologie, CHU de Rennes, Rennes 8 Médecine interne, Centre Hospitalier Régional Universitaire de Lille, Lille 9 Heor department, Boehringer Ingelheim France, Paris 10 Pneumologie, Hopital Louis Pradel, Bron | ||||
https://doi.org/10.1016/j.rhum.2020.10.078 |
||||
, Article | ||||
, France | ||||
Abstract: https://www.sciencedirect.com/science/article/abs/pii/S1169833020302726 | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Respiratory disease | 2020 | French | , Methodology, Observational study, Population Based Study | |
Healthcare Resource Utilization and Associated Costs of Progressive Fibrosing Interstitial LUNG Disease (PF-ILD) and Systemic Sclerosis Associated Interstitial LUNG Disease (SSC-ILD) in France. | ||||
M. Nasser P. Rabiéga L. Boussel S. Si-Mohamed V. Barbet S. Marque J. Massol D. Revel F. Thivolet-Bejui L. Chalabreysse D. Maucort-Boulch S. Jouneau E. Hachulla V. Cottin | ||||
1 University Claude Bernard, Lyon, France, 2 IQVIA, La Défense, 92, France, 3 Hospices Civils de Lyon, Lyon, France, 4 IQVIA, La Défense, France, 5 AIXIAL, Paris, France, 6 Université de Rennes 1, CHU Rennes, INSERM, EHESP, Rennes, France, 7 Hôpital Claude Huriez, Centre National de Référence des maladies auto-immunes systémiques, CHRU de Lille, Lille, France, 8 National Coordinating Reference Center for Rare Pulmonary Diseases, Louis Pradel Hospital, University Claude Bernard, Lyon, France | ||||
DOI:https://doi.org/10.1016/j.jval.2020.08.1891 |
||||
, Article | ||||
, France | ||||
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(20)34147-4/fulltext | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Respiratory disease | 2020 | English | , Observational study, Population Based Study | |
Prevalence and mortality of systemic sclerosis-associated interstitial lung disease (SSc-ILD) using the French national health insurance system (SNDS) database in France | ||||
Mouhamad Nasser, Sophie Larrieu, Loic Boussel, Salim Si-Mohamed, Fabienne Bazin, Sébastien Marque, Jacques Massol, Didier Revel, Francoise Thivolet-Bejui, Lara Chalabreysse, Delphine Maucort-Boulch, Eric Hachulla, Stéphane Jouneau, Vincent Cottin | ||||
1 Hospices Civils de Lyon, Lyon, France 2 IQVIA, Bordeaux, France 3 AIXIAL, Paris, France 4 CHU de Lille, Lyon, France 5 CHU de Rennes, Lyon, France | ||||
European Respiratory Journal 2020 56: 805; DOI: 10.1183/13993003.congress-2020.805 |
||||
, Article | ||||
, France | ||||
Abstract: https://erj.ersjournals.com/content/56/suppl_64/805.article-info | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Respiratory disease | 2020 | English | , Observational study, Population Based Study | |
REAL WORLD OUTCOMES OF ADJUVANTED TRIVALENT INFLUENZA VACCINE COMPARED TO FLUZONE-HD AND EGG-BASED QUADRIVALENT AND TRIVALENT VACCINES AMONG THE US ELDERLY DURING 2016-2018 FLU SEASONS USING CLAIMS DATA | ||||
Victoria Divino, Joaquin Mould-Quevedo, Miao Jiang, Mitchell DeKoven, Girishanthy Krishnarajah | ||||
IQVIA; Seqirus | ||||
Conference. Options X for the Control of Influenza. Singapore, 28 August - 1 September 2019 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Respiratory disease | 2019 | English | , Retrospective database analysis | |
HOSPITALIZATION ENCOUNTERS FOLLOWING VACCINATION WITH ADJUVANTED TRIVALENT INFLUENZA VACCINE COMPARED TO FLUZONE-HD AND EGG-BASED QUADRIVALENT AND TRIVALENT VACCINES AMONG THE US ELDERLY USING CLAIMS DATA | ||||
Victoria Divino, Joaquin Mould-Quevedo, Mitchell DeKoven, Miao Jiang, Girishanthy Krishnarajah | ||||
IQVIA; Seqirus | ||||
Conference. Options X for the Control of Influenza. Singapore, 28 August - 1 September 2019 |
||||
, Poster | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Respiratory disease | 2019 | English | , Retrospective database analysis | |
AN EARLY LOOK AT THE SECOND DOSE COMPLETION OF THE RECOMBINANT ZOSTER VACCINE (RZV) IN CANADIAN ADULTS ? A RETROSPECTIVE ANALYSIS | ||||
Ashleigh McGirr1, Tara Bourgoin2, Michael Wortzman1, Brad Millson2, Shelly McNeil3 | ||||
1GSK, Mississauga, Canada, 2IQVIA, Ot tawa, Canada, 3Canadian Center for Vaccinology, IWK Heal th Centre and Nova Scotia Health Authority, Dalhousie University | ||||
The CIRN Annual Meeting, 20 & 21 November 2019 - Toronto, Canada |
||||
, Poster | ||||
, Canada | ||||
Abstract: https://gsk.envisionpharma.com/dv_gsk_bio/ | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2019 | English | , Retrospective database analysis | |
PIN151 PATIENTS TREATED FOR HEPATITIS C: AN OBSERVATIONAL STUDY WITH THE FRENCH ADMINISTRATIVE HEALTH CARE DATABASE (SNDS) | ||||
Pol S,1 Rodriguez I,2 Fouad F,3 Lemaitre M,3 Ansolabehere X,4 Lada O,2 Roudot-Thoraval F | ||||
1 Hopital Cochin - APHP, Paris, France, 2 Gilead Sciences, Paris, France, 3 IQVIA, COURBEVOIE, France, 4 QuintilesIMS, Paris La Défense, France, 5 Henri Mondor hospital, Créteil, France | ||||
DOI:https://doi.org/10.1016/j.jval.2019.09.1391 |
||||
, Abstract | ||||
, France | ||||
Abstract: https://www.valueinhealthjournal.com/article/S1098-3015(19)33769-6/fulltext | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Infectious disease | 2019 | English | , Observational study, Population Based Study, Predictive analytics | |
Évolution de la prise en charge de l’hépatite C en France : étude observationnelle réalisée à partir des données du Système national des données de santé | ||||
F. Fayssoil , M. Lemaitre , X. Ansolabehere , I. Rodriguez | ||||
a IQVIA, Courbevoie, France b Gilead Sciences, Boulogne Billancourt, France | ||||
Doi : 10.1016/j.respe.2019.04.025 |
||||
, Abstract | ||||
, France | ||||
Abstract: https://www.em-consulte.com/article/1292586/article/evolution-de-la-prise-en-charge-de-l-hepatite-c-en | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Infectious disease | 2019 | French | , Methodology, Observational study, Population Based Study | |
Determinants of shingles vaccine acceptance in the United Kingdom | ||||
Hélène Bricout 1, Laurence Torcel-Pagnon 1, Coralie Lecomte 2, Mariana F Almas 3, Ian Matthews 4, Xiaoyan Lu 5, Ana Wheelock 6, Nick Sevdalis 7 | ||||
Sanofi Pasteur, LYON, France. 2IQVIA, Ouen cedex, France. 3IQVIA, Berkshire, United Kingdom. 4MSD Ltd, Maidenhead, United Kingdom. 5MSD Vaccins, LYON, France. 6Department of Surgery and Cancer, National Institute for Health Research Imperial Patient Safety Translational Research Centre, Imperial College London, London, United Kingdom. 7Centre for Implementation Science, King's College London, London, United Kingdom | ||||
PLoS One. 2019 Aug 1;14(8):e0220230 |
||||
, Article | ||||
, UK | ||||
Abstract: https://pubmed.ncbi.nlm.nih.gov/31369608/ | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2019 | English | , Clinical setting: Primary care, Patient questionnaire, Public Health | |
Lessons learned on enhanced passive safety surveillance of influenza vaccines. | ||||
Khalife N., Almas M, Stam Morago, M, Negreiro F, Costa L, Projetto, S | ||||
1IQVIA, Reading, UK; 2IQVIA, Geneva, Switzerland; 3IQVIA, Lisbon, Portugal; 4IQVIA, Dublin, Ireland; 5IQVIA, Milan, Italy | ||||
Pharmacoepidemiol & Drug Saf 2018;27(2):495 |
||||
, Poster | ||||
Abstract: https://onlinelibrary.wiley.com/doi/full/10.1002/pds.4629 | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2018 | English | , Clinical setting: Primary care, Database Study, direct to patient research, Epidemiological study | |
Observational safety study of specific outcomes after trivalent cell culture seasonal influenza vaccination (Optaflu® ) among adults in THIN database of electronic UK primary healthcare records | ||||
Hall GC, Davies PTG, Karim MY, Haag MDM & O'Leary C | ||||
Seqirus | ||||
Pharmacoepidemiology and Drug Safety |
||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2018 | English | , Retrospective database analysis | |
Epidemiologic and economic burden of HPV diseases in Spain: implication of additional 5 types from the 9-valent vaccine. | ||||
López N1, Torné A2, Franco A3, San-Martin M1, Viayna E4, Barrull C4, Perulero N4. | ||||
1Medical Affairs, MSD, Madrid, Spain.22Gynecologic Oncology Unit, Institut Clinic of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clínic-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Faculty of Medicine, University of Barcelona, Barcelona, Spain.33Diagnostic Unit of Urology, Clinic Institute of Nephrology and Urology (ICNU) Hospital Clínic Barcelona, University of Barcelona, Barcelona, Spain.4Health Economics and Outcomes Research, Real World Insights, IQVIA, Barcelona, Spain. | ||||
Infect Agent Cancer. 2018 May 2;13:15. |
||||
, Article | ||||
, Spain | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/29743937 | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Immunology and Vaccination, Infectious disease, Oncology | 2018 | English | , Burden of illness, clinical setting: Secondary care, Literature Review, Review, Survey research | |
The economic burden of CIDP in the United States: A case-control study. | ||||
Divino V, Mallick R, DeKoven M, Krishnarajah G | ||||
IQVIA; CLS Behring | ||||
Journal. PLoS One. 2018 Oct 23;13(10):e0206205. |
||||
, Article | ||||
, USA | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/30352101 | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2018 | English | , Cost of illness, Retrospective database analysis | |
Predictors and diseasburden of ulcerative colitis progression in Sweden. | ||||
Stålhammar J1,Hällström P1, Agreus L2, Beydogan H3, Arnheim Dahlström L3, Skup M4, Lee W-J4 | ||||
1 Uppsala University, Uppsala, Sweden 2 Karolinska Institutet, Stockholm, Sweden 3 QuintilesIMS, Stockholm, Sweden 4 AbbVie Inc., North Chicago, USA. | ||||
UEG Barcelona September 2017 |
||||
, Abstract | ||||
, Nordic, Sweden | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2017 | English | , Retrospective cohort analysis | |
Market share and switching dynamics between Etanercept and its biosimilar product in Sweden and Germany: a real-world preliminary analysis. | ||||
Alten R1, Neregård P2, Jones HE3, Meng T4, Curiale C5, Singh E6, Lucchese L7, Gossen N8, Bergman GJ9, Miglio C7 | ||||
1 Shlosspark-Klinik Teaching Hospital of the Charité, Berlin, Germany 2 Pfizer, Sollentuna, Sweden 3 Pfizer inc., Collegeville, PA, USA 4 Pfizer Pharma GmbH, Berlin, Germany 5 Pfizer, Rome, Italy 6 Pfizer Inc., Collegeville, PA, USA 7 QuintilesIMS, London, UK 8 QuintilesIMS, Frankfurt, Germany 9 QuintilesIMS, Solna, Sweden | ||||
ISPOR 20th Annual European Congress |
||||
, Germany, Nordic, Sweden | ||||
Abstract: https://www.ispor.org/Event/ProgramList/2017Glasgow?type=Poster&sess=II&acode=PSY | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Patient Registries & Real-World Study Methods, Rheumatology | 2017 | English | , Retrospective database analysis | |
Compliance with vaccination against hepatitis A virus in Germany: a retrospective analysis | ||||
Jacob L, Kostev K | ||||
Int J Clin Pharmacol Ther. 2017 Jul 24. doi: 10.5414/CP202990. [Epub ahead of print] |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Pediatrics | 2017 | English | , Retrospective cohort analysis | |
Compliance with vaccination against tick-borne encephalitis virus in Germany | ||||
Jacob L, Kostev K | ||||
Clin Microbiol Infect. 2017 Jan 28. pii: S1198-743X(17)30045-9. doi: 10.1016/j.cmi.2017.01.012. [Epub ahead of print] |
||||
, Article | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2017 | English | ||
Direct and Indirect Protection with Pediatric Quadrivalent Live-Attenuated Influenza Vaccination in Europe Estimated by a Dynamic Transmission Model | ||||
Gerlier L1, Hackett J2, Lawson R2, Dos Santos Mendes S3, Weil-Olivier C4, Schwehm M5, Eichner M6,7 | ||||
1 QuintilesIMS, Real-World Evidence Solutions, Zaventem, Belgium 2 AstraZeneca, Gaithersburg, MD, USA 3 AstraZeneca, Brussels, Belgium (Current affiliation: MSD, Brussels, Belgium) 4 Department of Pediatrics, University Paris VII, Paris, France 5 ExploSYS GmbH, Leinfelden-Echterdingen, Germany 6 Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany 7 Epimos GmbH, Dusslingen, Germany | ||||
JHEOR 2017;5(1):89-108 |
||||
, Article | ||||
, Australia, Belgium, Finland, France, Germany, Greece, Italy, Luxembourg, Netherlands, Poland, Portugal, Spain, Sweden, UK | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Infectious disease, Respiratory disease | 2017 | English | , Epidemiological study, Public Health | |
Epidemiologic and economic burden of HPV-related diseases in Spain: Potential benefit of adding 5 additional types in the nonavalent vaccine. | ||||
López N1, Torné A2, Franco A3, San-Martin M1, Viayna E4, Barrull C4, Perulero N4 | ||||
1 Medical Affairs, Sanofi Pasteur MSD, Madrid, Spain 2 Gynecologic Oncology Unit, Institut Clinic of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clínic-Institut d′Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Faculty of Medicine, University of Barcelona, Barcelona, Spain 3 Diagnostic Unit of Urology, Clinic Institute of Nephrology and Urology (ICNU) Hospital Clínic Barcelona, University of Barcelona, Barcelona, Spain 4 Health Economics and Outcomes Research, IMS Health, Barcelona, Spain | ||||
HPV2017 31st International papillomavirus conference, 2017, February 28 – March 4, Cape Town, South Africa |
||||
, Poster | ||||
, Spain | ||||
Abstract: http://hpv2017.org/Documents/HPV%202017%20Final%20Program%20SPIRAL.pdf | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Health economics, Immunology and Vaccination, Oncology | 2017 | English | , Burden of illness, Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Literature Review, Survey research | |
Impacto económico de las enfermedades asociadas al VPH en España: beneficio potencial de la vacuna nonavalente frente a la tetravalente [Economic impact of HPV-associated diseases in Spain: potential benefit of nonvalorent versus tetravalent vaccine]. | ||||
López N1, Torné A2, Franco A3, San-Martin M1, Viayna E4, Barrull C4 | ||||
1 Medical Affairs, MSD, Madrid, Spain 2 Gynecologic Oncology Unit, Institut Clinic of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clínic-Institut d′Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Faculty of Medicine, University of Barcelona, Barcelona, Spain 3 Diagnostic Unit of Urology, Clinic Institute of Nephrology and Urology (ICNU) Hospital Clínic Barcelona, University of Barcelona, Barcelona, Spain 4 Health Economics and Outcomes Research, IMS Health, Barcelona, Spain | ||||
XXXVII Jornadas de Economía de la Salud, 2017, 6 - 8 de septiembre, Barcelona, España |
||||
, Poster | ||||
, Spain | ||||
Abstract: http://www.aes.es/jornadas/en/ | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Health economics, Immunology and Vaccination, Oncology | 2017 | Spanish | , Burden of illness, Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Literature Review, Survey research | |
Estimación de la carga epidemiológica de patologías asociadas a 9 genotipos del virus del papiloma humano en España: revisión de la literatura [Estimating the epidemiological burden of pathologies associated with 9 human papillomavirus genotypes in Spain: Literature review]. | ||||
Lopez N1, Viayna E2, Perulero N2, San-Martin M1 | ||||
1 Sanofi Pasteur-MSD 2 Quintiles IMS | ||||
Vacunas. 2017;18(2):36-42 |
||||
, Article | ||||
, Spain | ||||
Abstract: http://www.elsevier.es/es-revista-vacunas-72-avance-resumen-estimacion-carga-epidemiologica-patologias-asociadas-S1576988716300644?referer=buscador | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Health economics, Immunology and Vaccination, Oncology | 2017 | Spanish | , Burden of illness, Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Literature Review | |
Carga epidemiológica y económica de las patologías asociadas al virus del papiloma humano en españa: revisión de la literatura [Epidemiological and economic burden of pathologies associated with human papillomavirus in Spain: literature review]. | ||||
Lopez N1, Viayna E2, Perulero N2, San-Martin M1 | ||||
1 Sanofi Pasteur-MSD 2 Quintiles IMS | ||||
XXXVII Jornadas de Economía de la Salud, 2017, 6 - 8 de septiembre, Barcelona, España |
||||
, Poster | ||||
, Spain | ||||
Abstract: http://www.aes.es/jornadas/en/ | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Health economics, Immunology and Vaccination, Oncology | 2017 | Spanish | , Burden of illness, Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Literature Review | |
Outcome Evaluation of a Subcutaneous Immunoglobulin Clinical Management Progra | ||||
Julia Zhu, Gretchen Ayer, Heather S. Kirkham, Chen Chichang, Ron L. Wade, Swapna Karkare, Chet H. Robson, Jordan S. Orange | ||||
Walgreen Co. QuintilesIMS, Plymouth Meeting, PA | ||||
American Journal of Pharmacy Benefits |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2017 | English | , Retrospective cohort analysis | |
Clinical and economic outcomes of a 'high-touch' clinical management program for intravenous immunoglobulin | ||||
Julia Zhu, Heather S. Kirkham, Gretchen Ayer, Chen Chichang, Ron L. Wade, Swapna Karkare, Chet H. Robson, Jordan S. Orange | ||||
Walgreen Co. QuintilesIMS, Plymouth Meeting, PA | ||||
ClinicoEconomics and Outcomes Research |
||||
, Article | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2017 | English | , Population Based Study, Retrospective cohort analysis | |
Observational safety study of specific outcomes after trivalent cell culture seasonal influenza vaccination (Optaflu®) among adults in THIN database of electronic UK primary healthcare records | ||||
Gillian C. Hall1 | Paul T.G. Davies2 | M. Yousuf Karim3 | Mendel D.M. Haag4 | Caroline O'Leary5 | ||||
Grimsdyke House, London, UK 2 Northampton General Hospital NHS Trust, Northampton, UK 3 Frimley Park, Royal Surrey County, St Peter's Hospitals, Surrey, UK 4 Seqirus, Amsterdam, The Netherlands 5QuinitilesIMS Ltd, London, UK | ||||
Pharmacoepidemiol Drug Saf. 2017;1–7. |
||||
, Article | ||||
, UK | ||||
Abstract: https://doi.org/10.1002/pds.4347 | ||||
Condition | Year | Language | Analysis type | |
, Drug safety, Immunology and Vaccination | 2017 | English | , Retrospective database analysis | |
Cross-cultural validation of Lupus Impact Tracker in five European clinical practice settings | ||||
Schneider M, Mosca M, Pego-Reigosa JM, Gunnarsson I, Maurel F, Garofano A, Perna A, Porcasi R, Devilliers H | ||||
Policlinic of Rheumatology, Hiller Research Unit, Heinrich-Heine University, Düsseldorf, Germany. Department of Internal Medicine, Rheumatology Unit, University of Pisa, Pisa, Italy. Department of Rheumatology, Complexo Hospitalario Universitario de Vigo, Ourense y Pontevedra, Spain. Department of Medicine, Unit of Rheumatology, Karolinska Institutet, Solna, Sweden. HEOR, Real-World Evidence Solutions (RWES) unit, IMS Health, Paris-La Défense, France. Global Specialty Pharma Franchise, GlaxoSmithKline; Services Unlimited, Brentford, UK. Immunology Medical Department, GlaxoSmithKline spa, Verona, Italy. Department of Internal Medicine and Systemic Diseases, University Hospital of Dijon, 5bis INSERM U866 5ter INSERM CIC-EC 1432, Dijon, France. | ||||
Rheumatology (Oxford). 2017 May 1;56(5):818-828 |
||||
, Article | ||||
, France, Germany, Italy, Spain, Sweden | ||||
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/28204765 | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Rheumatology | 2017 | English | , Retrospective Field Study | |
Translation of the UK paediatric influenza primary school vaccination programme to 13 European countries using a dynamic transmission model. | ||||
Gerlier L1, Hackett J2, Lawson R2, Dos Santos Mendes S3, Martin Eichner4,5 | ||||
1 QuintilesIMS, Zaventem, Belgium 2 AstraZeneca, Gaithersburg, MD, USA 3 AstraZeneca, Uccle, Belgium 4 Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany 5 Epimos GmbH, Dusslingen, Germany | ||||
19th ISPOR Annual European Congress, 2016, October 29- November 2, Vienna, Austria |
||||
, Abstract | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2016 | English | ||
Factors associated with influenza vaccine uptake during a universal vaccination programme of preschool children in England and Wales: a cohort study | ||||
Hardelid P, Rait G, Gilbert R, Petersen I | ||||
Population, Policy and Practice Programme, UCL Institute of Child Health; PRIMENT Clinical Trials Unit, Research Department of Primary Care and Population Health; Research Department of Primary Care and Population Health, University College London | ||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2016 | English | , Retrospective database analysis | |
The Burden of Ulcerative Colitis and Crohn’s Disease in Spain | ||||
Cortés X1, Fernández-Salazar L2, Márquez L3, Ramos L4, Díaz Rubio C5, Planellas L6, Gasche D6 | ||||
1Gastroenterology Section, Internal Medicine of Hospital Universitario de Sagunto. University CEU Cardenal Herrera, Department of Medicine, Valencia; 2Department of Gastroenterology of Hospital Clínico Universitario de Valladolid; Department of Gastroenterology of Hospital del Mar de Barcelona; 4Department of Gastroenterology of Hospital Universitario de Canarias; 5Market Access Department, AbbVie; 6HEOR-RWE, IMS Health | ||||
Revista Española de la Economía de Salud (EDS). 2016;11(5):902-913 |
||||
, Article | ||||
, Spain | ||||
Abstract: http://www.economiadelasalud.com/Articulo.aspx?i=n5d018 | ||||
Condition | Year | Language | Analysis type | |
, Gastrointestinal disorders, Health economics, Immunology and Vaccination | 2016 | English | , Burden of illness, Clinical setting: hospital, Survey research | |
Allergy immunotherapy prescribing trends for grass pollen-induced allergic rhinitis in Germany: a retrospective cohort analysis. | ||||
McDonell A,Wahn U,Demuth D,Richards C,Hawes C,Andreasen J N,Allen-Ramey F | ||||
1Real-World Evidence Solutions and Health Economics & Outcomes Research, IMS Health, 210 Pentonville Road, London N1 9JY, UK. 2Department for Pediatric Pneumology and Immunology, Charité Medical University, Berlin, Germany. 3Worked at IMS Health at time of study, Real-World Evidence Solutions and Health Economics & Outcomes Research, London, UK. 4Global Market Access, ALK-Abelló A/S, Hørsholm, Denmark. 5Global Health Outcomes, Merck & Co., West Point, PA 19486, USA. | ||||
Allergy, Asthma & Clinical Immunology (2015) 11:19 |
||||
, Manuscript in preparation | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Infectious disease, Respiratory disease | 2015 | English | , Retrospective database analysis | |
The incidence of Kawasaki disease after vaccination within the UK pre-school National Immunisation Programme: an observational THIN database study | ||||
Hall GC, Tulloh RM, Tulloh LE | ||||
Grimsdyke House; Bristol Royal Hospital for Children; | ||||
, Article | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2015 | English | , Retrospective database analysis | |
OC-035 Association of oral and intravenous iron with the probability of hospitalisation in england | ||||
S Keshav, C Chapman, S Tomkins, L Mills, B Jackson | ||||
West Middlesex University Hospital/ IQVIA / Vifor Pharma/ John Radcliffe Hospital and University of Oxford | ||||
, Editorial | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2015 | English | , Retrospective database analysis | |
Trends In Prescribing Of Specific Immunotherapy For Grass Pollen Allergy In Germany: 2005-2012 | ||||
Wahn U1, McDonell A2, Richards C2, Allen-Ramey F3, Andreasen J4, Hawes C2, Demuth D2 | ||||
1Dept. of Ped. Pneumology and Immunology, Charite, Berlin, Germany, 2IMS Health, London, UK, 3Merck, West Point, Pennsylvania, 4ALK, Horsholm, Denmark | ||||
American Academy of Allergy Asthma & Immunology, San Diego, CA, USA |
||||
, Abstract | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2014 | English | , Retrospective database analysis | |
Public health and economic impact of vaccinating children with a quadrivalent live attenuated influenza vaccine in France using a dynamic transmission model. | ||||
Gerlier L1, Weil-Olivier C2, Carrat F3, Lenne X4, Lamotte M1, Greneche S5, Eichner M6,7 | ||||
1IMS Health, Vilvoorde, Belgium 2Professor of pediatrics, University Paris VII, France 3AP–HP, UMR-S 707, Paris, France 4Department of Medical Information, University Lille Nord de France, Lille, France 5AstraZeneca, Rueil-Malmaison, France 6Epimos Gmbh, Dusslingen, Germany 7Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Germany | ||||
ISPOR 17th Annual European Congress, 8-12 November, Amsterdam, The Netherlands |
||||
, Abstract, Poster | ||||
, France | ||||
Abstract: www.ispor.org | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Infectious disease, Respiratory disease | 2014 | English | , Cost effectiveness, Cost utility | |
Impact of patient programs on adherence in inflammation and immunology: A global systematic review and meta-analysis of published evidence | ||||
Burudpakdee C1, Khan ZM, Gala S, Nanavaty M, Kaura S | ||||
1 IMS Health, Alexandria, VA, US | ||||
ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2014 | English | , Population Based Study | |
Pediatric trends in prescribing of specific immunotherapy for grass pollen allergy in Germany: 2005-2012 | ||||
Wahn UH1, Norgaard Andreasen J2, McDonell A3, Richards C3, Allen-Ramey F4, Demuth D3 | ||||
1 Allergy and Immunology, Berlin, Germany, 2 ALK-Abelló, Horsholm, Denmark, 3 IMS Health, London, UK, 4 Merck, West Point, US | ||||
European Academy of Allergy and Clinical Immunology Congress 7-11 June 2014, Copenhagen, Denmark |
||||
, Poster | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2014 | English | , Retrospective database analysis | |
Trends in first prescriptions of specific immunotherapy for grass pollen allergy in Germany: 2005-2012 | ||||
Norgaard Andreasen J1, Wahn U2, McDonell A3, Richards C3, Allen-Ramey F4, Demuth D3 | ||||
1 ALK-Abelló, Horsholm, Denmark, 2 Pediatric Allergy and Immunology, Berlin, Germany, 3 IMS Health, London, UK, 4 Merck, West Point, US | ||||
European Academy of Allergy and Clinical Immunology Congress 7-11 June 2014, Copenhagen, Denmark |
||||
, Poster | ||||
, Germany | ||||
Abstract: http://www.professionalabstracts.com/eaaci2014/planner/index.php?go=abstract&action=abstract_iplanner&print=0&lprID=1690&highlight=wahn&PSID=DWJLDURMOSTVZOWHRYYC | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2014 | English | , Retrospective database analysis | |
Autoimmune thyroiditis as a risk factor for stroke: a historical cohort study | ||||
Karch A & Thomas SL | ||||
Department of Epidemiology (A.K.), Helmholtz Centre for Infection Research, Braunschweig, Germany; Faculty of Epidemiology & Population Health (A.K., S.L.T.), London School of Hygiene and Tropical Medicine, UK; and Department of Neurology (A.K.), University Medical Center Göttingen, Germany. | ||||
Neurology. 2014 May 6;82(18):1643-52. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24719488 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Endocrinology, Immunology and Vaccination, Neurological disorders | 2014 | English | , Retrospective database analysis | |
Descriptive investigation of the recording of influenza vaccination details on The Health Information Network database. | ||||
Hall GC & Hill F | ||||
Cegedim | ||||
Pharmacoepidemiol Drug Saf. 2014 Jun;23(6):595-600. doi: 10.1002/pds.3515. Epub 2013 Sep 30. |
||||
, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/24123471 | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Infectious disease | 2014 | English | , Retrospective database analysis | |
Coût du Lupus Systémique (LS) en France des patients adultes avec une maladie active et traitée (étude LUCIE) | ||||
Amoura Z1, Deligny C2, Pennaforte JL3, Hamidou M4, Blanco P5, Hachulla E6, Pourrat J7, Queyrel V8, Garofano A9, Maurel F9, Levy-Bachelot L10, Boucot I10. | ||||
1Service de médecine interne 2, Centre national de référence lupus, hôpital La Pitié-Salpétrière, 47-83, boulevard de l'Hôpital, 75651 Paris cedex 13, France. 2Service de médecine interne et rhumatologie, CHU de Fort-de-France, BP 63297261, Fort-de-France cedex, Martinique. 3Service de médecine interne, hôpital Robert-Debré, rue du Général-Koenig, 51090 Reims, France. 4Service de médecine interne, hôpital Hôtel-Dieu, place Alexis-Ricordeau, 44093 Nantes cedex 1, France. 5Service de médecine interne, hôpital Pèllegrin, place Amélie-Rabat-léon, 33076 Bordeaux cedex, France. 6Service de médecine interne, hôpital Huriez, 1, place de Verdun, 59037 Lille cedex, France. 7Service de néphrologie et immunologie clinique, hôpital Rangueil, 1, avenue du Professeur-Jean-Pouhlès TSA 50032, 31059 Toulouse cedex 9, France. 8Service de médecine interne, hôpital l'Archet, 151, route Saint-Antoine-Ginestière BP 79, 06202 Nice cedex 3, France. 9IMS Real-World Evidence Solutions, Health Economics & Outcomes Research, Tour Ariane, 5-7, place de la Pyramide, 92088 La Défense cedex, France. 10GlaxoSmithKline, 100, route de Versailles, 78163 Marly-le-Roi cedex, France. | ||||
Rev Med Interne. 2014 Nov;35(11):700-8 |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Nephrology, Rheumatology | 2014 | French | , Cost of illness, Observational study, Retrospective Field Study | |
Patterns of systemic lupus erythematosus expression in Europe | ||||
Cervera R1, Doria A2, Amoura Z3, Khamashta M4, Schneider M5, Guillemin F6, Maurel F7, Garofano A7, Roset M8, Perna A9, Murray M10, Schmitt C11, Boucot I12 | ||||
1. Departmeent of Autoimmune Diseases, Hospital Clinic, Barcelona Spain, 2. Division of Rheumatology, University of Padova, Italy, 3. Internal medecine Department 2, la pitié Salpetrière Hospital, Paris France, 4. Lupus research Unit, The Rayne inistitue Lambeth Wing, St Thomas 'Hospital London, England, 5. Policlinic of Rheumatology, Heinrich-Heine University, Germany, 6. INSERM CIC-EC, CHU Nancy, France, 7. IMS HEOR, Paris La Défense France, 8. IMS HEOR, Barcelona Spain, 9. Immuno Inflammation & infectious diseases Global Franchise, GSK, UK, 10. Access to Medicine Centre of Excellence GSK, UK, 11. Global Health Outcomes GSK, UK, 12. Medical Dpt GSK, Marly-le-Roi France | ||||
Autoimmunity Reviews - Volume 13, Issue 6, June 2014, Pages 621-629 |
||||
, Article, Manuscript in preparation | ||||
, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Clinical practice, Dermatology, Immunology and Vaccination, Musculoskeletal disease, Neurological disorders | 2014 | English | , Epidemiological study, Observational study, Prospective study | |
Annual direct medical cost of active systemic lupus erythematosus in five European countries. | ||||
Doria A1, Amoura Z, Cervera R, Khamastha MA, Schneider M, Richter J, Guillemin F, Kobelt G, Maurel F, Garofano A, Perna A, Murray M, Schmitt C, Boucot I. | ||||
1Division of Rheumatology, University of Padova, , Padova, Italy. | ||||
Ann Rheum Dis. 2014 Jan;73(1):154-60 |
||||
, Article | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Nephrology, Rheumatology | 2014 | English | , Observational study | |
Implementation of a pharmacy-based adult vaccine benefit: recommendations for a commercial health plan benefit. | ||||
Ko KJ1, Wade RL2, Yu HT, Miller RM, Sherman B, Goad J. | ||||
1 Cerner Research, 600 Corporate Pointe, Ste. 320, Culver City, CA 90230, USA. 2 IMS Health, Parsippany, New Jersey; | ||||
J Manag Care Spec Pharm. 2014 Mar;20(3):273-82 |
||||
, Article | ||||
, USA | ||||
Abstract: http://www.jmcp.org/doi/pdf/10.18553/jmcp.2014.20.3.273 | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2014 | English | , Literature Review, Public Health | |
Herpes Zoster-Related Health Care Resource Utilization in Cancer Patients in 5 European Countries | ||||
Gebremeskel B.G.1, Lopez-Gonzalez L.2, Patwardhan P.3, Chin J.4, Schwalm M.S.4, Acosta C.J.3,Margolis J.M.5 | ||||
VALUE IN HEALTH 17 ; A684 |
||||
, Abstract | ||||
, Belgium, France, Germany, Italy, Spain | ||||
Condition | Year | Language | Analysis type | |
, Health economics, Immunology and Vaccination, Oncology | 2014 | English | , Cost of illness, Retrospective database analysis | |
Design of Lupus Impact Tracker (LIT) Validation Study in Five European Clinical Practice Settings | ||||
M. Schneider, M. Mosca, J.M. Pego-Reigosa, V. Koscielny, L. Moore-Ramdin, H. Devilliers | ||||
1Heine-University Heinrich Düsseldorf, Düsseldorf, Allemagne ; 2Université de Pise, Pise, Italie ; 3Hospital faire Meixoeiro, Vigo, en Espagne ; 4GlaxoSmithKline, Londres, Angleterre ; 5CHU de Dijon, Dijon, France. | ||||
ISPOR 16th 02/06 Novembre 2013 Dublin |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Nephrology, Rheumatology | 2013 | English | ||
Health problems most commonly diagnosed among young female patients during visits to general practitioners and gynecologists in France before the initiation of the human papillomavirus vaccination program. | ||||
Van Ganse E1, Letrilliart L, Borne H, Morand F, Robain M, Siegrist CA | ||||
1Pharmacoepidemiology, CHU-Lyon, Lyon, France | ||||
Pharmacoepidemiol Drug Saf. 2012 Mar;21(3):261-8. doi: 10.1002/pds.2243. Epub 2011 Nov 3 |
||||
, Article | ||||
, France | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/22052698 | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Infectious disease, Womens Health | 2012 | English | , Retrospective database analysis | |
A prospective observational safety study on MF59® adjuvanted cell culture-derived vaccine, Celtura® during the A/H1N1 (2009) influenza pandemic | ||||
Reynales H, Astudillo P, de Vallière S, Hatz C, Schlagenhauf P, Rath B, Velentgas P, Farina A, Sales-Carmona V, Groth N | ||||
Vaccine 2012; 30(45):6436-43 |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2012 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
Risk of Guillain-Barré syndrome after meningococcal conjugate vaccination | ||||
Velentgas P, Amato AA, Bohn RL et al | ||||
Velentgas P, Amato AA, Bohn RL |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2012 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
Retrospective chart review study of the cost of care of systematic lupus erythematousus (SLE)in 5 European coutries | ||||
Doria A1, Amoura Z 2, Richter J3, Cervera R4, Khamashta M5, Guillemin F6, Garofanno A7, Maurel F7, Roset M8, Perna A9, Schmitt C10, Ager M9, Boucot I11, Gonzalez MC Quire S10, Birch H10. | ||||
1. University of Padova, Padova, Italy, 2. Université Paris VI Pierre et Marie Courie, Paris, France, 3. Heinrich-Heine-University, Düsseldorf, Germany, 4. Hospital Clinic, Barcelona, Spain, 5. The Rayne Institute, London, United Kingdom, 6. Centre d'épidémiologie clinique, Vandoeuvre-les-Nancy, France, 7. IMS Health, Paris, France, IMS Health, Barcelona, Spain, 9. GlaxoSmithKline, Brentford, United Kingdom, 10. GlaxoSmithKline, Uxbrige, United Kingdom, 11. GlaxoSmithKline, Marly-le-Roi, France | ||||
Abstract - Presentation PSY17 for the 14th European congress of ISPOR 2011 |
||||
, Abstract | ||||
, France, Germany, Italy, Spain, UK | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2011 | English | , Cost analysis, Cost of illness, Epidemiological study, Observational study, Retrospective cohort analysis | |
The annual direct medical cost of systemic lupus erythematosus (SLE)patients and costs drivers (LUCIE study): French results. | ||||
Amoura Z1, Pennaforte JL2, Hamidou M3, Arfi S4, Lazaro E5, Hachulla E6, Pourrat J7, Queyrel V8, Aubin C9, Garofano A10, Levy-Bachelot L9, Maurel F10, Boucot I9 | ||||
1. Internal Medecine Department, La Pitié Salpetrière Hospital, Paris, France, 2. Internal Medecine Department, Robert Debré Hospital, Reims, France, 3. Internal Medecine Department, Hôtel Dieu Hospital, Nantes, France, 4. Internal Medecine and Rheumatology Department, Fort de France Hospital, Fort de France, France, 5. Internal Medecine Departmeent, Pellegrin Hospital, Boredeaux, France, 6. Internal Medecine Department, Hurriez Hospital, Lille, France, 7. Nephrology and Clinical Immunology Department, Rangueil Hospital, Toulouse, France, 8. Internal Medecine Department, l'Archet Hospital, Nice, France, 9. GlaxoSmithKline, Marly-le-Roi, France, 10. IMS Health, Puteaux, France | ||||
Abstract - Presentation PSY20 for the 14th European congress of Ispor 2011 |
||||
, Abstract | ||||
, France | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2011 | English | , Cost of illness, Economic evaluation, Observational study | |
The impact of pneumococcal conjugate vaccination on primary care consultations in the UK. | ||||
Trotter C, Petersen I, Sterne J, Hayward A. | ||||
UCL | ||||
SAPC Annual Scientific Meeting,Bristol. 2011 |
||||
, Abstract, Conference, Poster | ||||
, UK | ||||
Abstract: https://sapc.conference-services.net/reports/template/onetextabstract.xml?xsl=template/onetextabstract.xsl&conferenceID=2491&abstractID=499554 | ||||
Condition | Year | Language | Analysis type | |
, Health policy, Immunology and Vaccination | 2011 | English | , Retrospective database analysis | |
The Brighton Collaboration GBS Working Group. Guillain-Barré syndrome and Fisher syndrome: Case definitions and guidelines for collection, analysis, and presentation of immunization safety data | ||||
Sejvar JJ, Kohl KS, Gidudu J, Amato A, Bakshi N, Baxter R, Burwen DR, Cornblath DR, Cleerbout J, Page 24 of 24 Edwards KM, Heininger U, Hughes R, Khuri-Bulos N, Korinthenberg R, Law BJ, Munro U, Maltezou HC, Nell P, Oleske J, Sparks R, Velentgas P, Vermeer P, Wiznitzer M | ||||
Vaccine. 2011 Jan 10;29(3):599-612. doi: 10.1016/j.vaccine.2010.06.003. Epub 2010 Jun 18 |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2011 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
Resource implications and budget impact of managing cow milk allergy in the UK | ||||
Sladkevicius E, Nagy E, Lack G & Guest JF | ||||
Catalyst Health Economics Consultants, 34b High Street, Northwood, Middlesex | ||||
J Med Econ. 2010 Mar;13(1):119-28. doi: 10.3111/13696990903543242 |
||||
, Abstract, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20092426 | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Miscellaneous | 2010 | English | , Retrospective database analysis | |
Risk of Myocardial Infarction in UK Primary Care Patients with Hepatitis C Virus Infection | ||||
Kimberly Forde K, Kevin Haynes K, James Lewis J & LoRe V | ||||
Healthcore Inc | ||||
26th International Conference on Pharmacoepidemiology & Therapeutic Risk Management |
||||
, Poster | ||||
, UK | ||||
Abstract: https://vivo.upenn.edu/vivo/display/citfd287960 | ||||
Condition | Year | Language | Analysis type | |
, Cardiovascular disease, Immunology and Vaccination, Infectious disease | 2010 | English | , Retrospective database analysis | |
Anaphylaxis epidemiology in patients with and patients without asthma: a United Kingdom database review. | ||||
González-Pérez A, Aponte Z, Vidaurre CF, Rodríguez LA. | ||||
Centro Español de Investigación Farmacoepidemiológica, Madrid, Spain | ||||
J Allergy Clin Immunol. 2010 May;125(5):1098-1104.e1. doi: 10.1016/j.jaci.2010.02.009. Epub 2010 Apr 14. |
||||
, Abstract, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/20392483 | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Respiratory disease | 2010 | English | , Retrospective database analysis | |
A prospective observational study of US in-office pediatric influenza vaccination during the 2007-2009 influenza seasons: use and factors associated with increased vaccination rates | ||||
Bhatt P, Block SL, Toback SL, Ambrose CS | ||||
Clin Pediatr 2010; 49(10):954-63 |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2010 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
Outpatient urticaria diagnosis codes have limited predictive value for same-day influenza vaccine adverse event detection | ||||
Moore KM, Duddy A, Lee GM, Velentgas P, Burwen DR, Platt R, Brown JS | ||||
J Clin Epidemiol. 2010 Apr;63(4):407-11 |
||||
, Article | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2010 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
The cost-effectiveness of 13-valent pneumococcal conjugate vaccine (pcv13) compared to 7-valent pneumococcal conjugate vaccine (pcv7) for childhood vaccination in Germany. | ||||
Patel, R1, Kuchenbecker, U2, Bowrin, K1, Lloyd, A1 | ||||
1 IMS Health, London, UK 2 Wyeth Pharmaceuticals, Muenster, Germany | ||||
27th Annual Meeting of the European Society for Paediatric Infectious Diseases Brussels, Belgium, June 9-13, 2009 |
||||
, Poster | ||||
, Germany | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2009 | English | , Cost effectiveness | |
Paediatric vaccination programmes against HPV: an individual-based simulation model | ||||
Thompson, W1 | ||||
1 IMS Health, London, UK | ||||
27th Annual Meeting of the European Society for Paediatric Infectious Diseases Brussels, Belgium, June 9-13, 2009 |
||||
, Poster | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2009 | English | , Epidemiological study | |
The Cost-Effectiveness of the new Pneumococcal 13-Valent Conjugate Vaccine (Pcv13) for childhood and adult vaccination in the UK | ||||
Patel R1, Stoykova B2, Lloyd AC1, Willingham J2, Hollingsworth R2 | ||||
1IMS Health, London, UK, 2Wyeth, Maidenhead, Berkshire, UK | ||||
ISPOR 12th Annual European Congress, Paris, France, 24-27 October 2009 |
||||
, Poster | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2009 | English | , Cost effectiveness | |
A Comparison of the cost effectiveness of the 13-Valent (Pcv13) and 10-Valent Pneumococcal Conjugate Vaccines in the UK | ||||
Patel R1, Stoykova B2, Lloyd AC1, Willingham J2, Hollingsworth R2 | ||||
1IMS Health, London, UK, 2Wyeth, Maidenhead, Berkshire, UK | ||||
ISPOR Paris, France, 24-27, October 2009 |
||||
, Poster | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2009 | English | , Cost effectiveness | |
Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis. | ||||
Pelletier EM1, Ogale S2, Yu E2, Brunetta P2, Garg J2 | ||||
1IMS Health, Watertown, MA, USA, 2Genentech Inc., South San Francisco, CA, USA | ||||
Clinical Therapeutics, 2009, 31(11): 2653-2664 |
||||
, Manuscript in preparation | ||||
, USA | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2009 | English | , Cost analysis | |
An evaluation of the association between C-reactive protein, the change in C-reactive protein over one year, and all-cause mortality in chronic immune-mediated inflammatory disease managed in UK general practice | ||||
Poole CD, Conway P & Currie CJ | ||||
Pharmatelligence, Medicentre, University Hospital of Wales | ||||
Rheumatology (Oxford). 2009 Jan;48(1):78-82. doi: 10.1093/rheumatology/ken415. |
||||
, Abstract, Article | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19056800 | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2009 | English | , Retrospective database analysis | |
Implementation of rapid cycle analysis for detection of potential excess risk of adverse events following influenza vaccination: A policy maker’s guide | ||||
Brown JS, Velentgas P, Kuldorff M, Moore KM, Duddy A, Platt R | ||||
Prepared for Center for Biologics Evaluation and Research, Food and Drug Administration. 2009 |
||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2009 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
Implementation of rapid cycle analysis for detection of potential excess risk of adverse events following influenza vaccination: A policy maker’s guide | ||||
Brown JS, Velentgas P, Kuldorff M, Moore KM, Duddy A, Platt R | ||||
Prepared for Center for Biologics Evaluation and Research, Food and Drug Administration. 2009 |
||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2009 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
Estudio del impacto económico de la gripe en el medio laboral [A study of the economic impact of influenza on the labour environment] | ||||
Badia Llach X1, Roset Gamisans M1, de Agustín de Oro T2, Álvarez Sanz C2, García Pulgar M2 | ||||
1 Health Economics and Outcomes Research. IMS Health. Barcelona. 2 Roche Farma, S.A. Madrid | ||||
Medicina del Trabajo 2008;17(1):21-29 |
||||
, Article | ||||
, Spain | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2008 | Spanish | , Observational study | |
A realistic-age-structured, deterministic, compartmental, transmission model to estimate the cost-effectiveness of vaccination against seasonal influenza | ||||
Thompson WA1, Eggington SG1, Tucker D2 | ||||
1 IMS Health, London, UK 2 GlaxoSmithKline Biologicals, Rixensart, Belgium | ||||
ISPOR 2008 13th Annual International Congress |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2008 | English | , Cost effectiveness | |
Economic burden associated with the management of cervical dysplasia and genital warts in Belgium. | ||||
Annemans L, Rémy V, Lamure E, Spaepen E, Lamotte M, Muchada JP, Largeron N | ||||
Journal of Medical Economics, 2008, 11: 135-150 |
||||
, Manuscript in preparation | ||||
, Belgium | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/19450115 | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2008 | English | , Burden of illness | |
Cost-effectiveness of vaccination against seasonal influenza: a realistic-age-structured, deterministic, compartmental model | ||||
Thompson WA1, Eggington SG1, Tucker D2 | ||||
1 IMS Health, London, UK 2 GlaxoSmithKline Biologicals, Rixensart, Belgium | ||||
ISPOR 3rd Asia-Pacific Conference, 7th-9th September, Seoul, South Korea. |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2008 | English | , Cost effectiveness | |
Occurrence of lymphoma among patients with atopic dermatitis and/or treated with topical immunosuppressants in the United Kingdom. | ||||
Arellano FM, Arana A, Wentworth CE | ||||
GSk | ||||
24th International Conference on Pharmacoepidemiology. January 2008 |
||||
, Poster | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Immunology and Vaccination | 2008 | English | , Retrospective database analysis | |
Validation of cases of lymphoma in THIN | ||||
Arellano F, Conde E, Wentworth C, Schlienger R, Fernandez-Vidauure C & Arana A | ||||
GSK | ||||
24th International Conference on Pharmacoepidemiology. January 2008 Pharmacoepidemiology and Drug Safety 17(S87-S88) |
||||
, Abstract, Poster | ||||
, UK | ||||
Abstract: https://www.rtihs.org/publications/validation-cases-lymphoma-thin | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination, Oncology | 2008 | English | , Retrospective database analysis | |
Influenza and pneumococcal vaccination protect against all cause mortality in patients with chronic obstructive pulmonary diseases | ||||
Schembri S, Morant S, Winter J & MacDonald T | ||||
Pharmacoepidemiology and Drug Safety 17(S194) |
||||
, Abstract | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2008 | English | , Retrospective database analysis | |
Real-time assessment of 2007-2008 influenza vaccine coverage among pediatric practices | ||||
Bhatt P, Perez-Tselikis J, Ambrose CS, Hamilton H, Oleka N | ||||
Pediatric Academic Societies Annual Meeting. Poster. May 2008 |
||||
, Poster | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2008 | English | , RWLPR (Real-World Late Phase Research-quintiles | |
Evaluating the cost-effectiveness of vaccination and screening against cervical cancer using a discrete event simulation model | ||||
Thompson WA1, Kretzschmar M2 | ||||
1 IMS Health, London, UK 2 University of Bielefeld, Germany | ||||
24th International Papillomavirus Conference, Beijing, 5-9th November 2007 |
||||
, Poster | ||||
, UK | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2007 | English | , Cost effectiveness | |
Cost-effectiveness of heptavalent conjugate pneumococcal vaccine (Prevenar) in Germany: considering a high-risk population and herd immunity effects. | ||||
Lloyd A1, Patel N1, Scott DA1, Runge C2, Claes C3, Rose M4. | ||||
1 IMS Health incorporating Fourth Hurdle Consulting, London, UK 2 Wyeth Pharmaceuticals, Münster, Germany 3 Universität Hannover, Hannover, Germany 4 Childrens’ Hospital, Goethe University, Frankfurt, Germany | ||||
Eur J Health Econ 2008 Feb;9(1):7-15. Epub 2007 Mar 2 |
||||
, Manuscript in preparation | ||||
, Germany | ||||
Abstract: http://www.springerlink.com/content/0445788730g5102l/ | ||||
Condition | Year | Language | Analysis type | |
, Immunology and Vaccination | 2007 | English | , Cost effectiveness | |
Fertility rates in women with asthma, eczema, and hay fever: a general population-based cohort study. | ||||
Tata L J, Hubbard R B, McKeever T M, Smith C J P, Doyle P, Smeeth L, West J & Lewis S A | ||||
Division of Epidemiology and Public Health, School of Community Health Sciences, University of Nottingham | ||||
Am J Epidemiol. 2007 May 1;165(9):1023-30. Epub 2007 Jan 25. |
||||
, Abstract | ||||
, UK | ||||
Abstract: http://www.ncbi.nlm.nih.gov/pubmed/17255115 | ||||
Condition | Year | Language | Analysis type | |
, Dermatology, Immunology and Vaccination, Respiratory disease, Womens Health | 2007 | English | , Retrospective database analysis | |